Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/585366


Booming US Generic Drug Market


Description: The growth of generics markets in the US is in full swing. Realizing its importance in minimizing the healthcare cost, government is also taking initiative to promote this market. Over the past ten years (1999-2008), the generic drugs have saved US$ 734 Billion for the American healthcare system. With patents of several blockbuster drugs expiring in next 3-4 years, generic drugs sector of the US presents a promising and availing opportunity for big pharma players from Europe, Asia and other regions to invest.

The US generics market is forecasted to grow at a CAGR of around 9.2% during 2010-2012, says our recent research report “Booming US Generic Drug Market”. Currently, the market is characterized by the emergence of new products as patents of branded drugs are getting expired. This trend is likely to continue in next few years. Anticipating the future growth, big pharma players are making deals with some generics manufactures from Asian countries, like India, to access their products and market them in the US.

We have discovered that generics market is expected to grow more strongly due to global economic downturn. The people are buying more generic products in order to cut their healthcare cost. Although several challenges, such as price erosion and litigations from branded manufacturers, may hamper the growth, the overall growth prospects of the market remain good. In this regard, our report provides rational analysis of various factors which will drive this market segment over the forecasted period.

The report also provides extensive information on the generics market in the US, besides discussing the emerging trends like contract manufacturing and biogenerics. Thus, it provides valuable information to pharmaceutical & generics companies and investors looking to enter this market. Analysis and statistics regarding market size, growth, share, regulatory environment and trends in technology development have been thoroughly analyzed to provide clients a comprehensive overview of the market.


Contents: 1. Analyst View

2. Global Generic Drugs Market

3. US Generic Drugs Market
3.1 Pharmaceutical Market
3.1.1 Branded Drugs
3.1.2 Generic Drugs

4. Regulatory Environment
4.1 Drug Efficacy Study Implementation (DESI) Program
4.2 Hatch-Waxman Act
4.3 Patent Infringement Litigations
4.4 Para IV & the 180-day Marketing Exclusivity
4.5 FDA Requirements
4.6 Generic Initiative for Value & Efficiency (GIVE)

5. Emerging Market Trends
5.1 Patent Expiries of Key Drugs
5.2 Huge Cost Savings
5.3 Biogenerics
5.4 Contract Manufacturing
5.5 Drugs Packaging
5.6 Drugs Delivery
5.7 Favorable Political Environment
5.8 Ageing Population

6. Growth Inhibitors
6.1 Lawsuits
6.2 Entry Barriers
6.3 Price Erosion and Depleting Margins
6.4 Authorized Generics

7. Competitive Landscape
7.1 Market Share of Key Players
7.2 Profile of Key Players
7.2.1 Teva Pharmaceutical Industries Limited
7.2.2 Watson Pharmaceuticals, Inc.
7.2.3 Mylan Laboratories Inc.
7.2.4 Sandoz Inc.
7.2.5 Pfizer

8. Supporting Databases
8.1 Macroeconomic Indicators
8.2 Population
8.3 Demographics
8.4 Healthcare Expenditure
8.5 Healthcare Infrastructure
8.6 Major Causes of Mortality

List of Tables:
Table 3-1: Top Therapeutic Categories by Sales (Billion US$), 2008
Table 5-1: Blockbuster Drugs Going Off-patent Globally (2010 to 2012)
Table 5-2: Patent Expiry Dates for Biopharmaceuticals
Table 7-1: Top 10 Players by Sales in Pharmaceutical Market (Billion US$), 2008
Table 7-2: Top 10 Players by Prescriptions Dispensed in Generic Drugs Market (Million), 2008
Table 8-1: Number of Deaths due to Leading Causes (2006)

List of Figures:
Figure 2-1: Global - Wine Consumption (Billion Liter), 2004-2008
Figure 2-2: Global - Wine Consumption by Country (%), 2008
Figure 3-1: Global - Wine Production by Region (%), 2008
Figure 3-2: Global - Wine Production by Country (%), 2008
Figure 3-3: US - Share in Global Wine Consumption (2008)
Figure 3-4: Global - Wine Imports by Country (%), 2007
Figure 3-5: Global - Wine Exports by Country (%), 2008
Figure 4-1: Relative Risk of Death with Frequency of Wine Consumption
Figure 4-2: Reduction in Salmonella based Food Poisoning on Wine Consumption (Units/ml)
Figure 4-3: US - Per Capita Wine Consumption (Gallons), 2004-2008
Figure 4-4: US - Wine Consumption Frequency (%), 2006 & 2008
Figure 4-5: US - Core and Marginal Wine Consumer by Gender (%), 2008
Figure 4-6: US - Net Percent Gain/Loss in Wine Consumption by Generation (2008)
Figure 5-1: US - Wine Production (Million Gallons), 2004-2008
Figure 5-2: US - Number of Wineries (2005-2008)
Figure 5-3: US - Total Wine Sales (Million Gallons), 2004-2008
Figure 5-4: US - Total Wine Sales (Billion US$), 2004-2008
Figure 5-5: US - Wine Sales by Price Segment (%), 2008 & 2009
Figure 5-6: US - Forecast for Wine Sales (Million Gallons), 2009-2012
Figure 5-7: US - Forecast for Wine Sales (Billion US$), 2009-2012
Figure 5-8: US - Total Wine Sales by Product (%), 2008
Figure 5-9: US - Table Wine Sales (Million Gallons), 2004-2008
Figure 5-10: US - Forecast for Table Wine Sales (Million Gallons), 2009-2012
Figure 5-11: US - Table Wine Consumption (Million Cases), 2005-2008
Figure 5-12: US - Dessert Wine Sales (Million Gallons), 2004-2008
Figure 5-13: US - Forecast for Dessert Wine Sales (Million Gallons), 2009-2012
Figure 5-14: US - Champagne/Sparkling Wine Sales (Million Gallons), 2004-2008
Figure 5-15: US - Forecast for Champagne/Sparkling Wine Sales (Million Gallons), 2009-2012
Figure 5-16: US - Core Wine Consumption by Color Mix (%), 2008
Figure 5-17: US - Marginal Wine Consumption by Color Mix (%), 2008
Figure 5-18: US - Red Table Wine Sales (Million Gallons), 2007 & 2008
Figure 5-19: US - White Table Wine Sales (Million Gallons), 2007 & 2008
Figure 5-20: US - Blush Table Wine Sales (Million Gallons), 2007 & 2008
Figure 5-21: California - Number of Wineries (2005-2008)
Figure 5-22: California - Wine Production (Million Gallons), 2004-2008
Figure 5-23: Washington - Number of Wineries (2005-2008)
Figure 5-24: Washington - Total Grape Wine Production (Tons), 2005-2008
Figure 5-25: Washington - Grape Wine Production by Color (%), 2008
Figure 5-26: Oregon - Number of Wineries (2005-2008)
Figure 5-27: Oregon - Grape Wine Production (Tons), 2006-2008
Figure 5-28: Oregon - Total Wine Sales (Cases), 2005-2008
Figure 5-29: New York - Number of Wineries (2005-2008)
Figure 5-30: US - Total wine Imports (Billion US$), 2005-2008
Figure 5-31: US - Imported and Domestic Wine Consumption by Generation (%), 2008
Figure 5-32: US - Imported and Domestic Wine Consumption by Segment (%), 2008
Figure 5-33: US - Wine Exports (Million US$), 2005-2008
Figure 5-34: US - Wine Exports (Million Gallons), 2005-2008
Figure 5-35: US - Share of Export in Wine Production (2005-2008)
Figure 5-36: US - Wine Exports by Country (%), 2008
Figure 5-37: US - Wine Exports by Product (Million Hectoliter), 2006-2008
Figure 5-38: US - Wine Distribution Networks (%), 2006
Figure 6-1: US - Wine Purchasing Frequency of Core Drinkers by Price Point (2007)
Figure 6-2: US - Wine Purchasing Frequency of Marginal Drinkers by Price Point (2007)
Figure 6-3: US - Wine Industry Revenue by Price Category (%) 1995 & 2006
Figure 6-4: US - Key Premium Wine Consumers by Segment (%)
Figure 6-5: US - Adult Wine Consumer Segment (%), 2008
Figure 6-6: US - Core Wine Consumers by Generation (%), 2007
Figure 6-7: US - Marginal Wine Consumers by Generation (%), 2007
Figure 6-8: US - Number of Glasses per Occasion by Generation (2008)
Figure 6-9: US - Male and Female Wine Drinkers by Generation (%), 2008
Figure 7-1: US - Online Wine Purchases by Segment (%), 2005 & 2008


Companies Mentioned - Teva Pharmaceutical Industries Limited - Watson Pharmaceuticals, Inc. - Mylan Laboratories Inc. - Sandoz Inc. - Pfizer


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/585366

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 24/11/2009 09:57:42
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Booming US Generic Drug Market

Web Address:
http://www.researchandmarkets.com/reports/585366

Office Code:
OC8HJMSMOVUUX

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €806.00
CD ROM €1,075.00 + EUR€ 50.00 Shipping/Handling *
Hard Copy €1,075.00 + EUR€ 50.00 Shipping/Handling *
Electronic (PDF) - Enterprisewide €1,545.00
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 24/11/2009 09:57:42


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)